Evidence map›Paper›PMID 30135445›Full record

ArticleNature communications2018

Early cellular innate immune responses drive Zika viral persistence and tissue tropism in pigtail macaques.

Megan A O'Connor, Jennifer Tisoncik-Go, Thomas B Lewis, Charlene J Miller, Debra Bratt, Cassie R Moats, Paul T Edlefsen, Jeremy Smedley, Nichole R Klatt, Michael Gale and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Viruses · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Activated CD4Cell reports. Medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Megan A O'ConnorDepartment of Microbiology, University of Washington, Seattle, 98195, WA, USA.ORCID http://orcid.org/0000-0003-2127-5073
Jennifer Tisoncik-GoDepartment of Immunology, University of Washington, Seattle, 98109, WA, USA.
Thomas B LewisDepartment of Microbiology, University of Washington, Seattle, 98195, WA, USA.
Charlene J MillerDepartment of Pharmaceutics, University of Washington, Seattle, 98195, WA, USA.
Debra BrattWashington National Primate Research Center, Seattle, 98121, WA, USA.ORCID http://orcid.org/0000-0002-5822-5558
Cassie R MoatsWashington National Primate Research Center, Seattle, 98121, WA, USA.
Paul T EdlefsenVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, 98109, WA, USA.ORCID http://orcid.org/0000-0002-8393-8103
Jeremy SmedleyWashington National Primate Research Center, Seattle, 98121, WA, USA.ORCID http://orcid.org/0000-0003-3369-4662
Nichole R KlattWashington National Primate Research Center, Seattle, 98121, WA, USA.
Michael GaleDepartment of Immunology, University of Washington, Seattle, 98109, WA, USA.
Deborah Heydenburg FullerDepartment of Microbiology, University of Washington, Seattle, 98195, WA, USA. fullerdh@wanprc.org.
University of Washington · USOregon National Primate Research Center · USUniversity of Miami · USFred Hutch Cancer Center · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
West Nile Virus and host control of innate defensesU19AI083019 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL · 2009 to 2018
$22.5M
VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
NIAID NIH HHS T32 AI007140NIAID NIH HHS U19 AI083019NIH HHS P51 OD010425
6 · The paper itself

Abstract

The immunological and virological events that contribute to the establishment of Zika virus (ZIKV) infection in humans are unclear. Here, we show that robust cellular innate immune responses arising early in the blood and tissues in response to ZIKV infection are significantly stronger in males and correlate with increased viral persistence. In particular, early peripheral blood recruitment of plasmacytoid dendritic cells and higher production of monocyte chemoattractant protein (MCP-1) correspond with greater viral persistence and tissue dissemination. We also identify non-classical monocytes as primary in vivo targets of ZIKV infection in the blood and peripheral lymph node. These results demonstrate the potential differences in ZIKV pathogenesis between males and females and a key role for early cellular innate immune responses in the blood in viral dissemination and ZIKV pathogenesis.

Indexed as

AnimalsChemokine CCL2Immunity, InnateMacaca nemestrinaZika VirusZika Virus InfectionChemokine CCL2

Identifiers

PMID30135445
PMCPMC6105614
OpenAlexW2887864484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.